🔎 Trials Near Me

Gara Jalqabaatti › COPD

Qorannoo klinikaalii COPD Ameerikaa Keessatti hirmaatuu

Qorannoo 98 COPD f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.

Magaalota qorannoo baay'ee qaban

Naannoon

Qorannoo yeroo dhihootti haaromfaman

Takkalaa qorannoo (Ingiliffa)

Acoustic Waveform Respiratory Evaluation

Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 8 hanga 70 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06512064

Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

Namoota walitti qabaa jiraSadarkaa 3
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06961214

Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation

Namoota walitti qabaa jiraSadarkaa 3
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06959095

Evaluation of the Paramedic Evaluation for Acute COPD Exacerbation

Namoota walitti qabaa jira
Umuriin 40 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07072039

WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department

Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07558265

To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 40 hanga 85 · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07684820

Mindful Steps 2.0: Promoting Physical Activity in Patients With COPD and HF

Namoota walitti qabaa jira
Umuriin 40 fi ol · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT05934565

A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)

Namoota walitti qabaa jiraSadarkaa 3
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07780656

: Vascular Function in Health and Disease

Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT02966665

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 40 hanga 75 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07759245

A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.

Namoota walitti qabaa jiraSadarkaa 4
Umuriin 40 hanga 85 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07053423

A Study to Evaluate the Long-term Safety and Efficacy of Lunsekimig in Adult Participants With Chronic Obstructive Pulmonary Disease (COPD)

Namoota walitti qabaa jiraSadarkaa 3
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT07793409

An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema

Namoota walitti qabaa jira
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT06035120

A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT07646587

Nebulizer Versus Handheld Maintenance Therapy for Patients With COPD

Namoota walitti qabaa jiraSadarkaa 4
Umuriin 60 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT07816835

A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)

Namoota walitti qabaa jiraSadarkaa 3
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT07780669

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 40 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT07082738

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 40 fi ol · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT07059091

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

Namoota walitti qabaa jiraSadarkaa 3
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06883305

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

Namoota walitti qabaa jiraSadarkaa 3
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06878261

COPD Exacerbation Follow Up

Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 40 fi ol · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT07118306

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.